Inbiomotion and Source BioScience sign an exclusive agreement for MAF Test® in United Kingdom and Ireland
This pioneering test aids oncologists in predicting recurrence and survival rates in breast cancer patients and potential treatment eligibility to bisphosphonates Results showing the clinical utility of the test have been published in Lancet Oncology and the Journal of National CanSource Genomics expands sequencing portfolio with first UK commercial service on the Element Biosciences AVITI™ System
Cambridge, UK - Source Genomics, a part of the Source BioScience Group, announces their genomic laboratory expansion by adding an Element Biosciences AVITI™ System to its fleet of sequencers.
Source Genomics White Paper explores the transformative power of multi-omics in genomic research
Multiomics combines the various ‘omics disciplines that make up the complex landscape of life science research.
Optical Genome Mapping shines light on complex structural variants in Genome
Unlock a 25% discount today on all OGM services with Source Genomics, limited time only.
Source Genomics expands rapid Sanger sequencing services to the North of the UK
Cambridge, UK - Source Genomics, a part of the Source BioScience Group, announces their genomic laboratory expansion into the North of the UK for increased capacity of its Sanger sequencing services leading to faster turnaround times for data delivery.
Source LDPath Wins 2023 MedTech Breakthrough Award
Source LDPath's wins MedTech Breakthrough Award 2023 for "Best Hospital Technology Implementation" following the clinical success of their digital integration with East Kent Hospital NHS Foundation Trust.
Source BioScience expands genomic footprint
Source BioScience signals growth with the opening of new Cambridge Genomics and Precision Medicine Unit.
Leading UK Diagnostics provider Source LDPath expands AI capabilities with Ibex Medical Analytics
NHS Trusts Gain Access to Galen, Ibex's Multi-tissue AI Platform, Supporting Pathologists with Enhanced Diagnostic Accuracy and Efficiency
Ground-breaking digital approach helps cut pathology waiting times
An innovative partnership between East Kent Hospitals and digital pathology company Source LDPath, a part of SourceBio International plc, is helping to reduce pathology waiting times and improve patient care.
Source BioScience completes £18.5m strategic acquisition of LDPath Ltd to reimagine the future of pathology by combining cellular and digital pathology platforms
SourceBio International plc, a leading international provider of integrated state-of-the-art laboratory services and products, announces that it has agreed to purchase the entire issued capital of LDPath Limited (“LDP”), a London based leader in Digital Pathology testing services.